Dementia Mental and Behavioural Disorders Unspecified dementia
Conditions
Interventions
Staff participants in long-stay units randomised to the experimental arm will attend the DARES structured education reminiscence-based programme for staff (SERPS), which will be delivered over three d
starting with two consecutive days and a third day, 6 weeks later. The DARES research team will provide telephone support to staff participants during the study period (22-25 weeks post randomisation)
Sponsors
Health Research Board (Ireland)
Eligibility
Inclusion criteria
Inclusion criteria: Patients: 1. Residents who have lived in the residential unit for at least one month and are likely to be there for the duration of the study 2. Residents with dementia. Diagnosis may be determined in any of the following ways: 2.1. A formal diagnosis of dementia determined by the DSM-1V criteria for dementia (American Psychiatric Association 1995) 2.2. Any other diagnosis of dementia by a medical clinician 2.3. Resident is on anti-Alzheimer?s medications, including Aricept (donepezil), Ebixa (memantine) and Exelon (rivastigmine) 2.4. Nurses? judgement and/or nursing records advise that the person has dementia Study sites: Public and private long-stay units across the Western seaboard of the Republic of Ireland who meet the eligibility criteria will be invited to participate. 1. Have 17 residents with dementia who agree to take part 2. A commitment from management of the long-stay unit and the clinical staff to participate in the study
Exclusion criteria
Exclusion criteria: Patients: 1. Has a sensory impairment that, in the judgment of the nursing staff, impairs their ability to participate 2. Has an acute physical illness that, in the judgment of the nursing staff, impairs their ability to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life of residents as measured by the Quality of Life-AD (QOL-AD) instrument (Logsdon et al 1999). Current information as of 19/10/10: All outcomes will be assessed at baseline and at 18 to 22 weeks post randomisation. Initial information at time of registration: All outcomes will be measured at baseline and at 22 to 25 weeks post randomisation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Agitation, measured using the Cohen-Mansfield Agitation Inventory (CMAI) 2. Depression, measured using the Cornell Scale for Depression in Dementia 3. Staff attitudes to residents with dementia and perceived care burden will be assessed using a modified version of the Zarit Burden Interview Current information as of 19/10/10: All outcomes will be assessed at baseline and at 18 to 22 weeks post randomisation. Initial information at time of registration: All outcomes will be measured at baseline and at 22 to 25 weeks post randomisation. | — |
Countries
Ireland
Outcome results
None listed